What is the recommended duration of treatment with Keflex (cefalexin) for an adult patient with a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Keflex (Cephalexin) for UTI

For uncomplicated cystitis in adults, treat with cephalexin for 7 days, which is the standard duration supported by FDA labeling and clinical guidelines. 1

Treatment Duration by UTI Type

Uncomplicated Cystitis (Simple Bladder Infection)

  • 7 days is the recommended duration for uncomplicated cystitis in patients over 15 years of age 1
  • The FDA label specifically states cystitis therapy should be continued for 7 to 14 days, with 7 days being appropriate for straightforward cases 1
  • Guidelines recommend treating acute cystitis episodes with "as short a duration of antibiotics as reasonable, generally no longer than seven days" 2

Complicated UTI

  • 7 days for patients with prompt symptom resolution 2
  • 10-14 days for those with delayed response, regardless of whether a catheter remains in place 2
  • The European Association of Urology recommends 7-14 days for complicated UTI, with 14 days particularly for men when prostatitis cannot be excluded 2
  • Recent evidence supports that 5-7 day courses are as effective as 10-14 day courses for complicated UTI 2

Catheter-Associated UTI

  • 7 days with prompt symptom resolution 2
  • 10-14 days with delayed response 2
  • For younger women (≤65 years) with catheter-associated UTI without upper tract symptoms after catheter removal, a 3-day regimen may be considered 2

Dosing Considerations

Standard Dosing

  • 500 mg every 12 hours is the FDA-approved regimen for uncomplicated cystitis 1
  • Recent evidence confirms twice-daily dosing (500 mg BID) is as effective as four-times-daily dosing (500 mg QID) for uncomplicated UTI, with no difference in treatment failure rates (12.7% vs 17%, P=0.343) 3
  • The twice-daily regimen may improve adherence without compromising efficacy 3

Alternative Dosing

  • For more severe infections, 250 mg every 6 hours (four times daily) may be used 1
  • Daily doses should remain within 1-4 grams per day 1

Key Clinical Pitfalls

Common mistakes to avoid:

  • Do not extend treatment beyond 7 days for uncomplicated cystitis unless there is documented delayed response—this increases resistance risk without improving outcomes 2
  • Obtain urine culture before starting therapy to guide treatment, especially in complicated UTI where resistance is more likely 2
  • Do not treat asymptomatic bacteriuria in non-pregnant patients—this provides no benefit and promotes resistance 2
  • Replace indwelling catheters that have been in place ≥2 weeks before treating catheter-associated UTI, as biofilm on old catheters reduces treatment efficacy 2

When to Extend Treatment

Extend to 10-14 days if:

  • Patient remains febrile beyond 72 hours 2
  • Symptoms persist or worsen during initial treatment 2
  • Male patient where prostatitis cannot be excluded 2
  • Underlying urological abnormality cannot be corrected 2

Evidence Quality Note

The 7-day duration recommendation is based on FDA labeling (highest authority for drug use) 1 and supported by multiple international guidelines from the Infectious Diseases Society of America 2, American Urological Association 2, and European Association of Urology 2. Recent research confirms shorter courses (5-7 days) are non-inferior to longer courses (10-14 days) for most UTI types 2, supporting the trend toward shorter durations to minimize resistance development.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.